Moreover, that ATF5 contributes to cancer progression is further evidenced by its suppression of apoptosis in glioma and breast cancer cells,33,34 promotion of metastasis in neuroblastoma cells,35 and enhancement of drug resistance in pancreatic cancer cells.30 This evidence concerns the gene ATF5 and glioma.